Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
74
1.490
Why?
Head and Neck Neoplasms
14
2012
288
1.250
Why?
Carcinoma, Squamous Cell
12
2011
330
0.850
Why?
Neck
7
2018
98
0.690
Why?
Vascular Malformations
3
2010
105
0.640
Why?
Head
5
2018
71
0.610
Why?
Patients
1
2018
51
0.560
Why?
Flow Cytometry
7
2024
400
0.560
Why?
Terminal Care
1
2018
47
0.560
Why?
Hemangioma
3
2018
85
0.530
Why?
Attitude to Health
1
2018
192
0.520
Why?
Laryngectomy
3
2013
27
0.520
Why?
Laryngeal Neoplasms
2
2007
44
0.490
Why?
Quality of Life
3
2012
881
0.450
Why?
Carcinoma, Merkel Cell
4
2016
41
0.450
Why?
Laser Therapy
3
2011
76
0.450
Why?
Laryngeal Diseases
1
2013
12
0.400
Why?
Nuclear Proteins
6
2015
246
0.400
Why?
Herpes Simplex
1
2013
23
0.400
Why?
Parotid Diseases
1
2012
3
0.400
Why?
Neuromuscular Agents
1
2012
8
0.390
Why?
Botulinum Toxins, Type A
1
2012
14
0.390
Why?
Leukoplakia, Oral
1
2011
6
0.370
Why?
Aminolevulinic Acid
1
2011
8
0.370
Why?
Lasers, Dye
1
2011
10
0.370
Why?
Eating
1
2012
159
0.370
Why?
Photosensitizing Agents
1
2011
19
0.370
Why?
Photochemotherapy
1
2011
32
0.360
Why?
Survivors
1
2012
118
0.360
Why?
Photoacoustic Techniques
2
2024
24
0.350
Why?
Female
30
2024
28236
0.350
Why?
Humans
49
2024
52539
0.340
Why?
Neoplastic Cells, Circulating
4
2019
34
0.340
Why?
Middle Aged
21
2024
13094
0.330
Why?
Male
30
2024
26831
0.330
Why?
Cheek
1
2010
9
0.330
Why?
Lip
1
2010
11
0.330
Why?
Pain
1
2012
359
0.330
Why?
Facial Neoplasms
1
2010
22
0.320
Why?
Receptors, Progesterone
1
2009
66
0.310
Why?
Adult
21
2024
14160
0.310
Why?
Aged
16
2018
10197
0.310
Why?
Lymphatic Vessels
1
2009
44
0.300
Why?
Postoperative Complications
3
2012
1081
0.300
Why?
Skin Neoplasms
4
2016
500
0.300
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1030
0.290
Why?
Surgical Flaps
1
2009
110
0.290
Why?
Neoplasms
1
2018
1301
0.280
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.280
Why?
Laryngeal Nerves
1
2007
15
0.280
Why?
Melanoma
2
2022
279
0.270
Why?
Erythrocytes
2
2024
70
0.270
Why?
Factor VII
1
2007
3
0.270
Why?
Intracranial Arteriovenous Malformations
1
2007
32
0.260
Why?
Dilatation
2
2017
27
0.260
Why?
Malaria
2
2024
37
0.240
Why?
Adolescent
11
2024
6727
0.230
Why?
Gene Silencing
4
2009
120
0.230
Why?
Disease Models, Animal
3
2016
1481
0.220
Why?
Cell Proliferation
4
2016
1027
0.200
Why?
Melanoma, Experimental
2
2016
34
0.200
Why?
Retrospective Studies
10
2015
6662
0.200
Why?
Immunohistochemistry
8
2014
981
0.200
Why?
Treatment Outcome
7
2018
5484
0.190
Why?
Muscarinic Agonists
1
2002
11
0.190
Why?
Promoter Regions, Genetic
7
2015
474
0.190
Why?
Xerostomia
1
2002
4
0.190
Why?
Sjogren's Syndrome
1
2002
13
0.190
Why?
Plasmodium yoelii
1
2022
12
0.190
Why?
Endoscopy
2
2015
123
0.190
Why?
Thiophenes
1
2002
46
0.190
Why?
Nitric Oxide Synthase Type III
2
2013
83
0.190
Why?
Quinuclidines
1
2002
39
0.190
Why?
Transcription Factors
2
2015
566
0.180
Why?
Embolization, Therapeutic
3
2011
90
0.180
Why?
Veins
3
2010
74
0.180
Why?
Azepines
3
2016
21
0.170
Why?
Triazoles
3
2016
114
0.160
Why?
Child
10
2012
7220
0.160
Why?
Neoplasm Invasiveness
3
2010
278
0.150
Why?
Child, Preschool
8
2012
4058
0.150
Why?
Mast Cells
1
2018
55
0.150
Why?
Mice
10
2022
5944
0.140
Why?
Combined Modality Therapy
4
2018
638
0.140
Why?
Ki-67 Antigen
3
2013
58
0.140
Why?
Cricoid Cartilage
1
2017
11
0.140
Why?
Estradiol
1
2018
217
0.140
Why?
Trachea
1
2017
54
0.130
Why?
Mice, Nude
5
2016
235
0.130
Why?
Follow-Up Studies
3
2011
2293
0.130
Why?
Lasers, Semiconductor
2
2022
7
0.130
Why?
Biopsy
3
2015
603
0.130
Why?
Infant
7
2018
3715
0.130
Why?
Embolism
1
2016
18
0.130
Why?
Neoplasm Staging
2
2010
767
0.120
Why?
Benzoxazoles
1
2016
11
0.120
Why?
Matrix Metalloproteinase 2
1
2016
58
0.120
Why?
Qualitative Research
1
2018
360
0.120
Why?
Matrix Metalloproteinase 9
1
2016
87
0.120
Why?
Tracheotomy
1
2015
15
0.120
Why?
TOR Serine-Threonine Kinases
1
2016
82
0.120
Why?
Tracheal Stenosis
1
2015
13
0.120
Why?
Laryngostenosis
1
2015
12
0.120
Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.120
Why?
Aged, 80 and over
6
2015
3417
0.120
Why?
Larynx
2
2017
30
0.120
Why?
Pyrimidines
1
2016
200
0.110
Why?
Proto-Oncogene Proteins c-myc
1
2014
53
0.110
Why?
Disease Progression
3
2014
872
0.110
Why?
Fluorouracil
2
2004
58
0.110
Why?
Carcinoma
2
2012
137
0.110
Why?
Gene Expression Regulation, Neoplastic
3
2015
856
0.110
Why?
DNA Methylation
5
2009
583
0.110
Why?
Breast Neoplasms
2
2015
1205
0.110
Why?
Plasmodium falciparum
2
2024
23
0.100
Why?
Apoptosis
2
2016
1122
0.100
Why?
Animals
10
2022
13465
0.100
Why?
Mastication
1
2012
5
0.100
Why?
Trismus
1
2012
2
0.100
Why?
DNA, Neoplasm
2
2011
146
0.100
Why?
Adaptor Proteins, Signal Transducing
3
2009
200
0.100
Why?
Cisplatin
2
2004
285
0.100
Why?
Radiotherapy, Adjuvant
1
2012
64
0.100
Why?
Receptors, Cell Surface
1
2013
112
0.100
Why?
Recurrence
2
2011
682
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.090
Why?
Endothelium, Lymphatic
1
2011
8
0.090
Why?
Chemoradiotherapy
1
2012
50
0.090
Why?
Cross-Sectional Studies
3
2024
1682
0.090
Why?
Syndrome
1
2012
252
0.090
Why?
Antigens, CD
1
2013
215
0.090
Why?
Administration, Topical
1
2011
60
0.090
Why?
Epigenesis, Genetic
1
2015
403
0.090
Why?
Propranolol
1
2012
78
0.090
Why?
Lymphatic Abnormalities
1
2011
20
0.090
Why?
Immunoenzyme Techniques
4
2016
136
0.090
Why?
Microtubule-Associated Proteins
1
2011
64
0.090
Why?
Enteral Nutrition
1
2012
155
0.090
Why?
Deglutition Disorders
1
2012
79
0.090
Why?
Homeodomain Proteins
1
2011
81
0.090
Why?
Brain Neoplasms
1
2014
290
0.090
Why?
Diagnosis, Differential
2
2011
1045
0.090
Why?
Tumor Suppressor Proteins
1
2011
128
0.090
Why?
Weight Gain
1
2012
241
0.090
Why?
Risk Assessment
1
2015
1348
0.090
Why?
Epigenomics
1
2011
74
0.080
Why?
Xenograft Model Antitumor Assays
3
2016
222
0.080
Why?
Lip Neoplasms
1
2010
3
0.080
Why?
Neoplasm Proteins
2
2003
328
0.080
Why?
Diagnostic Imaging
1
2011
173
0.080
Why?
Neoplastic Stem Cells
1
2011
93
0.080
Why?
Neoplasm Recurrence, Local
2
2019
642
0.080
Why?
Hospitals, Teaching
1
2010
53
0.080
Why?
Lasers, Solid-State
1
2010
31
0.080
Why?
Survival Rate
3
2011
953
0.080
Why?
Neoadjuvant Therapy
1
2011
125
0.080
Why?
Medical Records
1
2010
87
0.080
Why?
Microsatellite Instability
1
2009
21
0.080
Why?
Vascular Surgical Procedures
1
2011
166
0.080
Why?
Melanins
1
2009
20
0.080
Why?
Mouth
1
2010
33
0.080
Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
Why?
Young Adult
3
2024
4326
0.080
Why?
Carcinoma, Medullary
1
2009
12
0.080
Why?
Pilot Projects
1
2011
719
0.080
Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
Why?
Receptors, Estrogen
1
2009
132
0.080
Why?
Immunotherapy
1
2011
244
0.080
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
24
0.070
Why?
Port-Wine Stain
1
2008
14
0.070
Why?
Muscle, Smooth, Vascular
1
2009
136
0.070
Why?
Blotting, Western
3
2016
593
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1372
0.070
Why?
Vascular Endothelial Growth Factor A
1
2008
187
0.070
Why?
Cytokines
1
2011
624
0.070
Why?
Thyroid Neoplasms
1
2009
116
0.070
Why?
Early Detection of Cancer
2
2022
184
0.070
Why?
Tumor Cells, Cultured
3
2016
448
0.070
Why?
Factor VIIa
1
2007
8
0.070
Why?
Jaw Diseases
1
2007
6
0.070
Why?
Practice Guidelines as Topic
1
2010
496
0.070
Why?
Infant, Newborn
2
2011
2884
0.070
Why?
Practice Management, Medical
1
2006
10
0.070
Why?
Osteonecrosis
1
2007
35
0.070
Why?
Postoperative Hemorrhage
1
2007
55
0.060
Why?
Tongue
1
2007
40
0.060
Why?
Bone Density Conservation Agents
1
2007
75
0.060
Why?
Diphosphonates
1
2007
92
0.060
Why?
Otolaryngology
1
2006
61
0.060
Why?
Cell Line, Tumor
3
2015
1435
0.060
Why?
Recombinant Proteins
1
2007
495
0.060
Why?
Prospective Studies
1
2011
2453
0.060
Why?
Skin
1
2008
420
0.060
Why?
Mice, Inbred NOD
2
2016
92
0.060
Why?
Cameroon
1
2024
2
0.060
Why?
Hemeproteins
1
2024
4
0.060
Why?
Mice, SCID
2
2016
182
0.060
Why?
Parasitemia
1
2024
6
0.060
Why?
Neoplasm Metastasis
2
2015
238
0.060
Why?
Malaria, Falciparum
1
2024
21
0.060
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.060
Why?
DNA Repair Enzymes
1
2004
43
0.050
Why?
Ataxia Telangiectasia
1
2004
6
0.050
Why?
Statistics, Nonparametric
1
2004
196
0.050
Why?
ROC Curve
1
2024
254
0.050
Why?
Polymerase Chain Reaction
4
2009
460
0.050
Why?
Genes, p16
1
2003
9
0.050
Why?
Lymph Node Excision
1
2004
133
0.050
Why?
Radiotherapy
1
2004
129
0.050
Why?
Magnetic Resonance Angiography
2
2018
67
0.050
Why?
Proteoglycans
1
2003
87
0.050
Why?
Magnetic Resonance Imaging
2
2007
1536
0.050
Why?
Antigens, Nuclear
2
2013
24
0.050
Why?
Transplantation, Heterologous
2
2013
78
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
582
0.050
Why?
Sensitivity and Specificity
1
2024
883
0.050
Why?
Longitudinal Studies
1
2024
745
0.050
Why?
Membrane Glycoproteins
1
2003
241
0.050
Why?
Double-Blind Method
1
2002
718
0.040
Why?
Survival Analysis
3
2009
673
0.040
Why?
Tryptases
1
2018
4
0.040
Why?
Estrogen Receptor beta
1
2018
54
0.040
Why?
Arkansas
1
2004
2029
0.040
Why?
Estrogen Receptor alpha
1
2018
85
0.040
Why?
Protein Transport
1
2018
183
0.040
Why?
Ultrasonography, Doppler
1
2018
41
0.040
Why?
Biopsy, Fine-Needle
2
2009
104
0.030
Why?
Cadaver
1
2017
95
0.030
Why?
Pressure
1
2017
103
0.030
Why?
Molecular Imaging
1
2016
28
0.030
Why?
Serum
1
2016
32
0.030
Why?
Risk Factors
3
2015
3953
0.030
Why?
Drug Synergism
1
2016
148
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
19
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2016
186
0.030
Why?
Acetylation
1
2015
96
0.030
Why?
Enhancer Elements, Genetic
1
2015
59
0.030
Why?
Keratin-20
1
2014
7
0.030
Why?
Mammography
1
2015
97
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2014
17
0.030
Why?
Drug Therapy, Combination
1
2016
400
0.030
Why?
Chromatin
1
2015
141
0.030
Why?
Prognosis
3
2004
2116
0.030
Why?
Cell Cycle Proteins
1
2015
168
0.030
Why?
HEK293 Cells
1
2014
231
0.030
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
38
0.030
Why?
Gene Expression Regulation
1
2018
1004
0.030
Why?
Comorbidity
1
2015
631
0.030
Why?
Down-Regulation
1
2014
344
0.030
Why?
Protein Binding
1
2015
670
0.030
Why?
Actins
1
2013
117
0.020
Why?
RNA, Messenger
1
2016
1139
0.020
Why?
Base Sequence
2
2004
634
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Predictive Value of Tests
1
2014
949
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
Why?
Cell Line
1
2014
1030
0.020
Why?
Tissue Culture Techniques
1
2011
43
0.020
Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
Why?
Gluconates
1
2011
1
0.020
Why?
Graft Survival
1
2011
161
0.020
Why?
Indomethacin
1
2011
36
0.020
Why?
Injections, Subcutaneous
1
2011
51
0.020
Why?
Interleukin-2
1
2011
69
0.020
Why?
Gene Expression Profiling
1
2016
1108
0.020
Why?
Carrier Proteins
2
2003
319
0.020
Why?
Time Factors
2
2007
2997
0.020
Why?
Cyclophosphamide
1
2011
172
0.020
Why?
Interleukin-1beta
1
2011
87
0.020
Why?
Interferon-gamma
1
2011
179
0.020
Why?
Drug Administration Schedule
1
2011
375
0.020
Why?
Glottis
1
2010
34
0.020
Why?
Disease-Free Survival
1
2011
464
0.020
Why?
Sclerotherapy
1
2010
47
0.020
Why?
Endothelial Cells
1
2011
283
0.020
Why?
Calcitonin
1
2009
30
0.020
Why?
Tumor Necrosis Factor-alpha
1
2011
395
0.020
Why?
Thyroidectomy
1
2009
61
0.020
Why?
Paraffin Embedding
1
2008
52
0.020
Why?
Mice, Transgenic
1
2009
563
0.020
Why?
Signal Transduction
1
2014
1707
0.020
Why?
Curettage
1
2007
13
0.020
Why?
Dental Care
1
2007
11
0.020
Why?
Mouth Floor
1
2007
5
0.020
Why?
Polyvinyl Alcohol
1
2007
10
0.020
Why?
Hyperbaric Oxygenation
1
2007
15
0.020
Why?
Collateral Circulation
1
2007
38
0.020
Why?
Pharyngeal Diseases
1
2007
12
0.020
Why?
Current Procedural Terminology
1
2006
11
0.020
Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
Why?
Cutaneous Fistula
1
2007
14
0.020
Why?
Neck Dissection
1
2007
29
0.020
Why?
Angiography
1
2007
116
0.020
Why?
Office Visits
1
2006
45
0.020
Why?
Fistula
1
2007
27
0.020
Why?
Salvage Therapy
1
2007
136
0.020
Why?
Genetic Predisposition to Disease
1
2009
528
0.020
Why?
Imidazoles
1
2007
124
0.020
Why?
Adrenal Cortex Hormones
1
2007
114
0.020
Why?
Preoperative Care
1
2007
174
0.020
Why?
Ultrasonography
1
2006
424
0.010
Why?
United States
1
2015
5225
0.010
Why?
Guanine
1
2004
40
0.010
Why?
DNA Adducts
1
2004
79
0.010
Why?
Methylation
1
2004
126
0.010
Why?
Syndecans
1
2003
37
0.010
Why?
Syndecan-1
1
2003
73
0.010
Why?
Base Pair Mismatch
1
2003
21
0.010
Why?
Cell Count
1
2003
144
0.010
Why?
Antineoplastic Agents
1
2011
1219
0.010
Why?
DNA Repair
1
2003
196
0.010
Why?
Alcohol Drinking
1
2003
236
0.010
Why?
Molecular Sequence Data
1
2003
770
0.010
Why?
Anti-Bacterial Agents
1
2007
802
0.010
Why?
Smoking
1
2003
517
0.010
Why?
Multiple Myeloma
1
2007
3050
0.010
Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description